Survey of Ophthalmology
Volume 47, Issue 4 , Pages 387-391 , July 2002

Blindness After Liver Transplant

References 

  1. Antunes NL, Small TN, George D. Posterior leukoencephalopathy syndrome may not be reversible. Pediatr Neurol. 1999;20:241–243
  2. Bakshi R, Shaikh ZA, Bates VE, Kinkel PR. Thrombotic thrombocytopenic purpura (brain CT and MRI findings in 12 patients). Neurology. 1999;52:1285–1288
  3. Bargallo N, Burrel M, Berenguer J, et al.  Cortical laminar necrosis caused by immunosuppressive therapy and chemotherapy. AJNR Am J Neuroradiol. 2000;21:479–484
  4. Bartynski WS, Grabb BC, Zeigler Z. Watershed imaging features and clinical vascular injury in cyclosporin A neurotoxicity. J Comput Assist Tomogr. 1997;21:872–880
  5. Coley SC, Porter DA, Calamante F. Quantitative MR diffusion mapping and cyclosporine-induced neurotoxicity. AJNR Am J Neuroradiol. 1999;20:1507–1510
  6. Debaere C, Stadnik T, De Maeseneer M, Osteaux M. Diffusion-weighted MRI in cyclosporin A neurotoxicity for the classification of cerebral edema. Eur Radiol. 1999;9:1916–1918
  7. Garcia-Escrig M, Martinez J, Fernandez-Ponsati J. Severe central nervous system toxicity after chronic treatment with cyclosporine. Clin Neuropharmacol. 1994;17:298–302
  8. Gay CT, Bodensteiner JB, Nitschke R, et al.  Reversible treatment-related leukoencephalopathy. J Child Neurol. 1989;4:208–213
  9. Gijtenbeek JM, van den Bent MJ, Vecht CJ. Cyclosporine neurotoxicity (a review). J Neurol. 1999;246:339–346
  10. Gopal AK, Thorning DR, Back AL. Fatal outcome due to cyclosporine neurotoxicity with associated pathological findings. Bone Marrow Transplant. 1999;23:191–193
  11. Hauben M. Cyclosporine neurotoxicity. Pharmacotherapy. 1996;16:576–583
  12. Hedges TR. Retrochiasmal disorders. In:  Albert DM,  Jakobiec FA editor. Principles and Practice of Ophthalmology (Clinical Practice). Philadelphia: WB Saunders; 1994;p 2628–39
  13. Hinchey J, Chaves C, Appignani B, et al.  A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334:494–500
  14. Ito Y, Arahata Y, Goto Y. Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome. AJNR Am J Neuroradiol. 1998;19:415–417
  15. Jansen O, Krieger D, Krieger S, Sartor K. Cortical hyperintensity on proton density-weighted images (an MR sign of cyclosporine-related encephalopathy). AJNR Am J Neuroradiol. 1996;17:337–344
  16. Mathy I, Gille M, Van Raemdonck F, et al.  Neurological complications of intravenous immunoglobulin (IVIg) therapy (an illustrative case of acute encephalopathy following IVIg therapy and a review of the literature). Acta Neurol Belg. 1998;98:347–351
  17. Nakamura M, Fuchinoue S, Sato S, et al.  Clinical and radiological features of two cases of tacrolimus-related posterior leukoencephalopathy in living related liver transplantation. Transplant Proc. 1998;30:1477–1478
  18. Pavlakis SG, Frank Y, Chusid R. Hypertensive encephalopathy, reversible occipitoparietal encephalopathy, or reversible posterior leukoencephalopathy (three names for an old syndrome). J Child Neurol. 1999;14:277–281
  19. Pratschke J, Neuhaus R, Tullius SG. Treatment of cyclosporine-related adverse effects by conversion to tacrolimus after liver transplantation. Transplantation. 1997;64:938–940
  20. Schwartz RB, Bravo SM, Klufas RA. Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy (CT and MR findings in 16 cases). AJR Am J Roentgenol. 1995;165:627–631
  21. Singh N, Bonham A, Fukui M. Immunosuppressive-associated leukoencephalopathy in organ transplant recipients. Transplantation. 2000;69:467–472
  22. Sugimoto T, Tsunoda S, Shindou K, et al: [A case of neuroleptic malignant syndrome associated with reversible leukoencephalopathy] Rinsho Shinkeigaku-Clinical Neurology 39:1147–9, 1999
  23. Tauboll E, Gerdts R, Gjerstad L. Cyclosporin A and brain excitability studied in vitro. Epilepsia. 1998;39:687–691
  24. Wijdicks EF, Wiesner RH, Krom RA. Neurotoxicity in liver transplant recipients with cyclosporine immunosuppression. Neurology. 1995;45:1962–1964
  25. Woo M, Przepiorka D, Ippoliti C, et al.  Toxicities of tacrolimus and cyclosporin A after allogeneic blood stem cell transplantation. Bone Marrow Transplant. 1997;20:1095–1098

PII: S0039-6257(02)00316-8

Survey of Ophthalmology
Volume 47, Issue 4 , Pages 387-391 , July 2002